Julie A. Vetalice, Author at ORTHOWORLD

Seikagaku and Ono Submit NDA for Injectable OA Treatment in Japan

Seikagaku and Ono Pharmaceutical submitted a new drug application for manufacturing and marketing approval for ONO-5704/SI-613 injectable in Japan for the treatment of OA.

Jan 06, 2020

PERCEIVE3D Update on Computer-Aided Surgery Solutions

ORTHOFLASH Robotics/Tech

PERCEIVE3D was granted two new patents protecting its surgical navigation technology that combines video-based tracking with Augmented Reality to provide guidance in arthroscopic and open orthopedic surgery.

Jan 06, 2020

Anika Therapeutics to Acquire Parcus Medical and Arthrosurface

Competitive Landscape Mergers & Acquisitions

Anika Therapeutics signed agreements to acquire Parcus Medical and Arthrosurface within 1Q20.

Jan 06, 2020

Nextremity Solutions Gains Clearance for Lesser TMT Joint Arthrodesis System

ORTHOFLASH Trauma

Nextremity Solutions received FDA 510(k) clearance to market the InCore® TMT system, a three-part construct for fixation for Lesser Tarsometatarsal Joint Arthrodesis.

Jan 06, 2020

Augmedics Launches xvision AR Surgical Guidance

ORTHOFLASH Robotics/Tech

Augmedics commenced the U.S. launch of the xvision™ augmented reality guidance system for spine surgery.

Jan 06, 2020

SeaSpine Launches Mariner Midline Posterior Fixation

ORTHOFLASH Spine

SeaSpine commenced the full commercial launch of the Mariner® Midline Posterior Fixation System, a less-invasive option to treat a range of spinal pathologies.

Jan 06, 2020

Medacta Gains FDA Clearance for MyShoulder Placement Guides

Joint Replacement ORTHOFLASH

Medacta was granted FDA 510(k) clearance to market MyShoulder Placement Guides for use with the Medacta Shoulder and associated instrumentation.

Jan 06, 2020

OrthoPediatrics Launches QuickPack Bone Graft Substitute

Orthobiologics ORTHOFLASH

OrthoPediatrics commenced U.S. launch of QuickPack™ synthetic bone graft substitute.

Dec 20, 2019

Naviswiss Receives New Funding

Investments The Numbers

Naviswiss closed a CHF 5 million (USD $5 million) round of private equity funding to support product development and entrance into new markets with its surgical navigation for joint replacement procedures.

Dec 20, 2019

DePuy Synthes, Zebra Medical to Partner on AI in Orthopedics

Company Updates Competitive Landscape

Zebra Medical Vision and DePuy Ireland entered into a global co-development and commercialization agreement to bring artificial intelligence opportunities to orthopedics.

Dec 19, 2019

Get the ORTHOWORLD Newsletter!

Contact Us